May 10, 2023 / 08:40PM GMT
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst
Okay. Perfect. Welcome to the Second Day of the BofA Healthcare Conference. I'm Geoff Meacham. I'm the senior biopharma analyst here. We're thrilled to have Kymera with us. And on stage with me is Nello Mainolfi, who is the Founder, President and CEO. I got the name right, right?
Nello Mainolfi - Kymera Therapeutics, Inc. - Co-Founder, President, CEO & Director
Perfect, Geoff. Love it.
Questions and Answers:
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research AnalystSo maybe to kick it off, Nello give us just a high-level view here and just talk through kind of targeted protein degradation and kind of where you guys sit?
Nello Mainolfi - Kymera Therapeutics, Inc. - Co-Founder, President, CEO & Director
Excellent. So first, Geoff, thank you for inviting us. This is a great conference. We love being here, and you guys do a really great job.
So